AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AMN - US0017441017 - Common Stock
19.58 USD
+0.28 (+1.45%)
Overall AMN gets a fundamental rating of 4 out of 10. We evaluated AMN against 102 industry peers in the Health Care Providers & Services industry. AMN has an average financial health and profitability rating. AMN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- AMN had positive earnings in the past year.
- In the past year AMN had a positive cash flow from operations.
- AMN had positive earnings in 4 of the past 5 years.
- AMN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- AMN has a Return On Assets of -12.88%. This is in the lower half of the industry: AMN underperforms 74.51% of its industry peers.
- With a Return On Equity value of -42.76%, AMN is not doing good in the industry: 70.59% of the companies in the same industry are doing better.
- The Return On Invested Capital of AMN (2.08%) is comparable to the rest of the industry.
- AMN had an Average Return On Invested Capital over the past 3 years of 13.14%. This is above the industry average of 9.21%.
- The 3 year average ROIC (13.14%) for AMN is well above the current ROIC(2.08%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROIC | 2.08% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
- Looking at the Operating Margin, with a value of 1.65%, AMN is in line with its industry, outperforming 47.06% of the companies in the same industry.
- AMN's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 29.37%, AMN is in line with its industry, outperforming 58.82% of the companies in the same industry.
- AMN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so AMN is still creating some value.
- AMN has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for AMN has been reduced compared to 5 years ago.
- AMN has a better debt/assets ratio than last year.
2.2 Solvency
- AMN has an Altman-Z score of 2.45. This is not the best score and indicates that AMN is in the grey zone with still only limited risk for bankruptcy at the moment.
- The Altman-Z score of AMN (2.45) is comparable to the rest of the industry.
- The Debt to FCF ratio of AMN is 3.80, which is a good value as it means it would take AMN, 3.80 years of fcf income to pay off all of its debts.
- AMN has a better Debt to FCF ratio (3.80) than 72.55% of its industry peers.
- A Debt/Equity ratio of 1.31 is on the high side and indicates that AMN has dependencies on debt financing.
- AMN has a Debt to Equity ratio of 1.31. This is in the lower half of the industry: AMN underperforms 64.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Altman-Z | 2.45 |
ROIC/WACC0.26
WACC7.93%
2.3 Liquidity
- A Current Ratio of 1.05 indicates that AMN should not have too much problems paying its short term obligations.
- AMN's Current ratio of 1.05 is on the low side compared to the rest of the industry. AMN is outperformed by 66.67% of its industry peers.
- AMN has a Quick Ratio of 1.05. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
- With a Quick ratio value of 1.05, AMN is not doing good in the industry: 60.78% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
- The earnings per share for AMN have decreased strongly by -51.29% in the last year.
- Measured over the past 5 years, AMN shows a small growth in Earnings Per Share. The EPS has been growing by 0.80% on average per year.
- Looking at the last year, AMN shows a very negative growth in Revenue. The Revenue has decreased by -11.42% in the last year.
- Measured over the past years, AMN shows a small growth in Revenue. The Revenue has been growing by 6.07% on average per year.
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
3.2 Future
- AMN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.82% yearly.
- AMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.40% yearly.
EPS Next Y-57.99%
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
EPS Next 5Y22.82%
Revenue Next Year-8.07%
Revenue Next 2Y-6.81%
Revenue Next 3Y-3.33%
Revenue Next 5Y4.4%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 10.36, the valuation of AMN can be described as reasonable.
- Based on the Price/Earnings ratio, AMN is valued cheaper than 91.18% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.32. AMN is valued rather cheaply when compared to this.
- Based on the Price/Forward Earnings ratio of 25.36, the valuation of AMN can be described as expensive.
- AMN's Price/Forward Earnings is on the same level as the industry average.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.30, AMN is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.36 | ||
| Fwd PE | 25.36 |
4.2 Price Multiples
- AMN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AMN is cheaper than 82.35% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, AMN is valued cheaply inside the industry as 98.04% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.38 | ||
| EV/EBITDA | 7.46 |
4.3 Compensation for Growth
- A cheap valuation may be justified as AMN's earnings are expected to decrease with -29.55% in the coming years.
PEG (NY)N/A
PEG (5Y)12.88
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
5. Dividend
5.1 Amount
- No dividends for AMN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NYSE:AMN (1/22/2026, 3:08:17 PM)
19.58
+0.28 (+1.45%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)02-18 2026-02-18/amc
Inst Owners109.44%
Inst Owner Change-0.06%
Ins Owners0.45%
Ins Owner Change4.87%
Market Cap752.07M
Revenue(TTM)2.72B
Net Income(TTM)-275.54M
Analysts69.23
Price Target20.84 (6.44%)
Short Float %5.8%
Short Ratio1.79
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.35%
Min EPS beat(2)53.64%
Max EPS beat(2)93.07%
EPS beat(4)4
Avg EPS beat(4)78.74%
Min EPS beat(4)52.24%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)44.14%
EPS beat(12)12
Avg EPS beat(12)33.45%
EPS beat(16)16
Avg EPS beat(16)27.33%
Revenue beat(2)1
Avg Revenue beat(2)0.79%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.64%
Revenue beat(4)3
Avg Revenue beat(4)2.05%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)1.02%
Revenue beat(16)11
Avg Revenue beat(16)1.39%
PT rev (1m)-1.38%
PT rev (3m)2.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)46.18%
EPS NY rev (1m)0%
EPS NY rev (3m)20.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)16.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.36 | ||
| Fwd PE | 25.36 | ||
| P/S | 0.28 | ||
| P/FCF | 3.38 | ||
| P/OCF | 2.82 | ||
| P/B | 1.17 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.46 |
EPS(TTM)1.89
EY9.65%
EPS(NY)0.77
Fwd EY3.94%
FCF(TTM)5.8
FCFY29.62%
OCF(TTM)6.94
OCFY35.46%
SpS70.73
BVpS16.78
TBVpS-10.76
PEG (NY)N/A
PEG (5Y)12.88
Graham Number26.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROCE | 2.81% | ||
| ROIC | 2.08% | ||
| ROICexc | 2.16% | ||
| ROICexgc | 6.84% | ||
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% | ||
| FCFM | 8.2% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexgc growth 3Y-38.44%
ROICexgc growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Debt/EBITDA | 4.12 | ||
| Cap/Depr | 27.3% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | 0.95 | ||
| Cash Conversion | 129.62% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 2.45 |
F-Score4
WACC7.93%
ROIC/WACC0.26
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
EPS Next Y-57.99%
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
Revenue Next Year-8.07%
Revenue Next 2Y-6.81%
Revenue Next 3Y-3.33%
Revenue Next 5Y4.4%
EBIT growth 1Y-66.5%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year103.44%
EBIT Next 3Y20.95%
EBIT Next 5YN/A
FCF growth 1Y-48.21%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-49.55%
OCF growth 3Y1.61%
OCF growth 5Y7.34%
AMN HEALTHCARE SERVICES INC / AMN FAQ
What is the fundamental rating for AMN stock?
ChartMill assigns a fundamental rating of 4 / 10 to AMN.
Can you provide the valuation status for AMN HEALTHCARE SERVICES INC?
ChartMill assigns a valuation rating of 5 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Fairly Valued.
How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?
AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 4 / 10.
What is the earnings growth outlook for AMN HEALTHCARE SERVICES INC?
The Earnings per Share (EPS) of AMN HEALTHCARE SERVICES INC (AMN) is expected to decline by -57.99% in the next year.